✦ LIBER ✦

6074 Bevacizumab (bev) combined with chemotherapy as 2nd-line treatment for metastatic colorectal cancer (mCRC): results from the phase II BEVACOLOR study

✍ Scribed by Bennouna, J.; Husseini, F.; Delord, J.P.; Borg, C.; Trillet-Lenoir, V.; Faroux, R.; Francois, E.; Ychou, M.; Chaaban, B.; Douillard, J.Y.

Book ID: 123096976
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 48 KB
Volume: 7
Category: Article
ISSN: 1359-6349
DOI: 10.1016/S1359-6349(09)71169-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Bevacizumab Combined With Chemotherapy i

Bevacizumab Combined With Chemotherapy in the Second-Line Treatment of Metastatic Colorectal Cancer: Results from the Phase II BEVACOLOR Study

✍ Jaafar Bennouna; Christophe Borg; Jean-Pierre Delord; Faress Husseini; Véronique 📂 Article 📅 2012 🏛 CIG Media Group, LP. 🌐 English ⚖ 312 KB

CPT-11 in combination with capecitabine

CPT-11 in combination with capecitabine as first line chemotherapy for metastatic colorectal cancer (MCRC): preliminary results of a phase I/II study

✍ Kerr, D.J.; Ten Bokkel Huinink, W.W.; Bakker, J.; Boussard, B.; Frings, S.; Nort 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 168 KB

3068 POSTER Capecitabine + irinotecan +

3068 POSTER Capecitabine + irinotecan + bevacizumab as first-line therapy for patients (pts) with metastatic colorectal cancer (MCRC): preliminary phase II study results

✍ S. Beslija; M. Banjin; S. Jungic; N. Obralic; G. Kecman-Malcic; I. Rakita; B. Sa 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 80 KB

Bevacizumab plus chemotherapy as first-l

Bevacizumab plus chemotherapy as first-line treatment for patients with metastatic colorectal cancer: Results from a large German community-based observational cohort study

✍ Stein, Alexander; Petersen, Volker; Schulze, Mathias; Seraphin, Jörg; Hoeffkes, 📂 Article 📅 2014 🏛 Informa plc 🌐 English ⚖ 406 KB

3061 POSTER Phase I/II study of novel or

3061 POSTER Phase I/II study of novel oral fluoropyrimidine S-1 in combination with oxaliplatin (SOX) as first-line chemotherapy for metastatic colorectal cancer (mCRC)

✍ M. Tahara; Y. Yamada; A. Ohtsu; K. Shirao; Y. Shimada; Y. Sasaki; W. Yamamoto; T 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 61 KB

6110 POSTER Combination Chemotherapy Wit

6110 POSTER Combination Chemotherapy With Capecitabine (C), Irinotecan (I) Oxaliplatin (O) and Bevacizumab (B) (XELOXIRIA) as First Line Treatment of Metastatic Colorectal Cancer (MCRC) – Preliminary Results of a Phase l-ll Trial

✍ Bazarbashi, S.; Aljubran, A.; Soudy, H.; Alzahrani, A.; Darwish, A.; Eltaigani, 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 41 KB